menu
    • menu

    Company profile for Orbital Therapeutics

    NEW Drugs in Dev: 2
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines to treat human disease in ways that were not previously possible. We are building a first-in-kind platform that integrates a critical mass of both established and emerging technologies and delivery mechanisms.With this access to state-of-the-art RNA and novel delivery technologies, Orbital aims to advance an expansive and...
    Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines to treat human disease in ways that were not previously possible. We are building a first-in-kind platform that integrates a critical mass of both established and emerging technologies and delivery mechanisms.With this access to state-of-the-art RNA and novel delivery technologies, Orbital aims to advance an expansive and transformational portfolio of RNA therapeutics across a range of human diseases, including in the areas of vaccines, immunomodulation, protein replacement and regenerative medicine.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Orbital TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Cambridge, MA
    Telephone
    Telephone
    +1 (508) 202-7224
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://orbitaltx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BMS Inks $1.5B Deal To Pull Orbital Into Its Sphere Of Influence
    BMS Inks $1.5B Deal To Pull Orbital Into Its Sphere Of Influence

    10 Oct 2025

    // PRESS RELEASE

    https://news.bms.com/news/corporate-financial/2025/Bristol-Myers-Squibb-Strengthens-and-Diversifies-Cell-Therapy-Portfolio-with-Acquisition-of-Orbital-Therapeutics/default.aspx

    PRESS RELEASE
    10 Oct 2025
    Share Share
    Orbital Showcases In Vivo CAR-T Therapy for Autoimmune Disease
    Orbital Showcases In Vivo CAR-T Therapy for Autoimmune Disease

    22 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250722381311/en/Orbital-Therapeutics-Presents-Non-Human-Primate-Data-for-In-Vivo-CAR-T-Therapy-with-Potential-Best-in-Class-Profile-for-Autoimmune-Disease

    BUSINESSWIRE
    22 Jul 2025
    Share Share
    Orbital Adds Biopharma Veteran Geno Germano To Board
    Orbital Adds Biopharma Veteran Geno Germano To Board

    06 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250306789950/en

    BUSINESSWIRE
    06 Mar 2025
    Share Share
    Orbital Therapeutics Appoints Anna Dixon as Senior Vice President
    Orbital Therapeutics Appoints Anna Dixon as Senior Vice President

    05 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240905242926/en

    BUSINESSWIRE
    05 Sep 2024
    Share Share
    Orbital Therapeutics Appoints Ron Philip as Chief Executive Officer
    Orbital Therapeutics Appoints Ron Philip as Chief Executive Officer

    03 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240903470903/en

    BUSINESSWIRE
    03 Sep 2024
    Share Share
    Orbital Therapeutics closes South San Francisco lab, eliminating some roles
    Orbital Therapeutics closes South San Francisco lab, eliminating some roles

    13 Nov 2023

    // ENDPTS

    https://endpts.com/orbital-therapeutics-closes-south-san-francisco-lab-eliminating-some-roles/

    ENDPTS
    13 Nov 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search